Filament Health Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	0.62	2.13	0.36	-	-
Revenue Growth (YoY)	-71.06%	484.63%	-	-	-
Gross Profit	0.62	2.13	0.36	-	-
Selling, General & Admin	3.41	5.64	4.35	5.71	0.19
Research & Development	0.52	0.79	0.84	1.39	-
Operating Expenses	4.38	6.64	5.58	7.27	0.19
Operating Income	-3.77	-4.51	-5.22	-7.27	-0.19
Interest Expense	-0.24	-0.37	-0.18	-0.04	-
Earnings From Equity Investments	-	-0.07	-	-	-
Other Non Operating Income (Expenses)	-0.96	-0.37	-0.47	0.02	-
EBT Excluding Unusual Items	-4.97	-5.32	-5.88	-7.29	-0.19
Merger & Restructuring Charges	-	-	-	-2	-
Impairment of Goodwill	-	-	-10.68	-	-
Other Unusual Items	-	-	0.02	-	-
Pretax Income	-4.97	-5.32	-16.54	-9.29	-0.19
Income Tax Expense	-	-	-0.07	-0.04	-
Net Income	-4.97	-5.32	-16.47	-9.25	-0.19
Net Income to Common	-4.97	-5.32	-16.47	-9.25	-0.19
Shares Outstanding (Basic)	237	188	170	147	87
Shares Outstanding (Diluted)	237	188	170	147	87
Shares Change (YoY)	26.48%	10.63%	15.38%	68.81%	-
EPS (Basic)	-0.02	-0.03	-0.10	-0.06	-
EPS (Diluted)	-0.02	-0.03	-0.10	-0.06	-
Free Cash Flow	-2.34	-4.25	-3.96	-5.54	-0.08
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.04	-0.00
Gross Margin	100.00%	100.00%	100.00%	-	-
Operating Margin	-610.99%	-211.70%	-1432.01%	-	-
Profit Margin	-805.97%	-249.75%	-4517.55%	-	-
Free Cash Flow Margin	-379.36%	-199.22%	-1085.91%	-	-
EBITDA	-3.55	-4.44	-5.16	-7.21	-
EBITDA Margin	-	-208.28%	-	-	-
D&A For EBITDA	0.22	0.07	0.06	0.06	-
EBIT	-3.77	-4.51	-5.22	-7.27	-0.19
EBIT Margin	-	-211.70%	-	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.